Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Saphnelo approved in EU for SLE
Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE
Stay updated with breaking news from Basic Concepts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE approved in ...
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosusSaphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosusAstraZeneca’s Saphnelo (anifrolumab) has been approved in the...
Some unfortunate or disastrous historic events like slavery, the holocaust, colonialism and the genocide of indigenous people have their roots in one category or race of people claiming superiority over others...
The Philippine Philharmonic Orchestra serenades kids dressed in space-themed costumes Last Sunday, in time for Halloween, the Cultural Center of the Philippines (CCP) presented “Tricks and Musical Treats: A PPO Family Concert.” Aimed at children and families watching online, the objective of the con